Fundraising Fox
Persist AI
YC W23Sacramento, US · Founded 2022 · Delaware corporation · 6 employees · 12 known investors
Find your way into Persist AI
10,995 people in our graph can introduce you to the Persist AI team.
Sign up to see every warm intro you have to Persist AI
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Persist AI team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
Also known as Persist AI Formulations Corp
Founders & leadership· Y Combinator alumni (W23)
Persist AI was founded in 2022 by Karthik Raman and Christopher Shelner.
Investors · 12
How we know: 2048 Ventures's portfolio page · funding news · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Global Brain's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: pioneerfund.vc · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: a partner's Signal profile · funding news · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Funding
SEC filings, press & company announcements$16.9M disclosed across 2 of 3 rounds · 2023–2025
- $12MSeries AMay 2025 · 2 sourcesSource ↗
▶$4.9MraisedApr 2023 · 27 investors · PharmaceuticalsRule 506(b)
- Christopher ShelnerExecutive Officer, Director
- Karthik RamanExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $4.9M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
The YC application· Winter 2023 batch
What they told YC
- Describe what your company does in 50 characters or less.
- The company helps pharmaceutical firms develop slow-release drugs faster.
- What is your company going to make? Please describe your product and what it does or will do.
- The founders offer a service that develops sustained-release drug formulations for pharmaceutical companies, targeting 50% faster and cheaper results than current methods, which typically take 3-5 years and $10M or more. They screen formulations at high throughput using lab automation and train machine learning models to predict outcomes from data rather than relying on scientists' intuition.
Summarized from the founders' answers on their Y Combinator profile.
Related companies · 6
Companies working in the same space as Persist AI.
In the news
Frequently asked questions
- What does Persist AI do?
- Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
- Who founded Persist AI?
- Persist AI was founded by Karthik Raman, Christopher Shelner in 2022.
- Who are Persist AI's investors?
- Persist AI's investors include 2048 Ventures, Global Brain, Good AI Capital, Jovono, Pioneer, Spero Ventures, Y Combinator, Ford Street Ventures and 4 more.
- How much funding has Persist AI raised?
- Persist AI has disclosed $16.9M raised across 2 of its 3 known rounds.
- Where is Persist AI headquartered?
- Persist AI is headquartered in Sacramento, US.